Representation of women and racial minorities in SGLT2 inhibitors and heart failure clinical trials
Our study found that women and racial minority individuals have remained underrepresented in recent heart failure studies. Although some progress has been made over the years, more work is needed to improve data reporting and address barriers to enrollment for women and racial minority individuals in clinical trials.
Authors
- Aaron H. Wolfson (ORCID: https://orcid.org/0000-0003-0918-8970)
- Chukwuemeka Umeh (ORCID: https://orcid.org/0000-0001-6574-8595)
- Sabina Kumar (ORCID: https://orcid.org/0000-0003-3851-9142)
- Eseosa Sanwo
- Bhagyashree Tiwari
- J. Nattiv
- Harpreet Singh Bhatia (ORCID: https://orcid.org/0000-0002-3964-2989)
- PUJA DARJI
- Tamanna Mohta
- Priya Hotwani
- Benson Eghreriniovo
- Payaam Mahdavian
- Rahul Gupta (ORCID: https://orcid.org/0000-0002-6690-2854)
- Gagan Kaur (ORCID: https://orcid.org/0000-0001-8188-3869)
- Raghav Dhawan
- Ajay Vaidya
Institutions
- University of Southern California (US)
- Cedars-Sinai Medical Center (US)
- Loma Linda University Medical Center (US)
- Loma Linda University (US)
- University of California San Diego (US)
- McLaren Macomb (US)
- Center for Global Health (US)
- Parkview Health (US)
Publication Details
- Journal
- IJC Heart & Vasculature
- Published
- 2024-10-20
- DOI
- https://doi.org/10.1016/j.ijcha.2024.101539
- Citations
- 2
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.72